Revolade (25mg) 28 Tablets
Revolade 25 mg Tablets contains eltrombopag, a thrombopoietin receptor agonist used to treat low platelet count (thrombocytopenia) in patients with certain blood disorders. It helps the body produce more platelets, reducing the risk of bleeding and bruising.
What is Revolade 25 mg Tablet?
Revolade (eltrombopag) is an oral medication prescribed for patients with low platelet counts due to immune or bone marrow disorders. It is commonly used in conditions where conventional therapy alone is insufficient to maintain safe platelet levels.
Uses of Revolade 25 mg Tablets
- Treatment of Chronic Immune Thrombocytopenia (ITP)
- Management of Aplastic Anemia
- Prevention and treatment of thrombocytopenia in Hepatitis C patients
- Reduces risk of bleeding complications
Benefits of Revolade 25 mg
- Stimulates platelet production effectively
- Reduces need for platelet transfusions
- Helps prevent serious bleeding episodes
- Improves quality of life for patients with chronic platelet disorders
- Convenient once-daily oral tablet
How Revolade Works
Revolade (eltrombopag) activates thrombopoietin (TPO) receptors in the bone marrow, promoting platelet production and maintaining safer platelet counts to prevent bleeding.
Side Effects of Revolade 25 mg Tablets
Common Side Effects
- Headache
- Nausea
- Fatigue
- Diarrhea
- Muscle or joint pain
Serious Side Effects
- Liver function abnormalities
- Blood clots (thrombosis)
- Cataracts (with long-term use)
- Severe allergic reactions (rare)
Precautions & Warnings
- Regular blood and liver function tests recommended
- Avoid taking with dairy products or calcium-containing supplements
- Use cautiously in patients with liver disease
- Not recommended during pregnancy or breastfeeding
- Follow your doctor’s dosage instructions strictly
Dosage & Administration
- Typically taken once daily on an empty stomach
- Take at least 1–2 hours before or after meals
- Avoid antacids or mineral supplements near dosing time
Packaging Information
- Pack size: 28 tablets
- Suitable for continuous therapy in chronic conditions
Conclusion
Revolade 25 mg Tablets (28’s) is an effective oral therapy for managing thrombocytopenia in patients with ITP, aplastic anemia, or hepatitis C. With proper monitoring, it helps maintain healthy platelet levels and reduces the risk of bleeding.